Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune reconstitution.

Drew Weissman1, Luis J Montaner

  • 1Division of Infectious Diseases, University of Pennsylvania, 522B Johnson Pavilion, Philadelphia, PA 19104, USA.

Clinics in Laboratory Medicine
|September 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Nature·2026
Same author

IgA is necessary and sufficient to prevent norovirus infection in mice.

Science translational medicine·2026
Same author

Antigen Stimulation Reactivates HIV-1 Proviruses Despite Integration in Repressive Chromatin.

bioRxiv : the preprint server for biology·2026
Same author

Decoupling Physisorption from Chemisorption in Clickable Lipid Nanoparticles.

ACS nanoscience Au·2026
Same author

Preventive and therapeutic efficacy of mRNA/LNP vaccines encoding HPV16 E6 and E7 in an early-intervention HPV tumor mouse models.

Human vaccines & immunotherapeutics·2026
Same author

Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumors.

Bioengineering & translational medicine·2026
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Restoring immune function in HIV-infected patients is crucial for long-term management. Understanding immune reconstitution can lead to strategies for better disease control and survival beyond current therapies.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Immune reconstitution after suppressive therapy may explain delayed HIV progression and increased survival.
  • Significant questions remain regarding the protective role of immune responses to HIV and their restoration.

Purpose of the Study:

  • To explore the mechanisms of immune reconstitution in HIV-infected patients.
  • To investigate the loss and potential restoration of anti-HIV CD4 responses.
  • To understand early immune system damage in HIV disease and its persistence despite viral control.

Main Methods:

  • This study is a review of current research and clinical observations.
  • Analysis of immune system dynamics in HIV-infected individuals on suppressive therapy.
  • Exploration of factors influencing immune recovery and viral control.

Related Experiment Videos

Main Results:

  • Immune reconstitution is a key factor in managing HIV, potentially offering improved survival and delayed progression.
  • The rapid loss of anti-HIV CD4 responses in progressors and methods for their restoration require further investigation.
  • Early immune damage in HIV may not be fully reversible by controlling viral replication alone.

Conclusions:

  • Immune reconstitution is a critical goal for long-term HIV management, especially where HAART is not universally accessible.
  • Future strategies may involve managing immune reconstitution, potentially alongside vaccines or other treatments.
  • Further research is needed to fully understand and harness immune recovery for improved HIV outcomes.